Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Obesity is a chronic condition and a key risk factor for a range of other health issues, including type 2 diabetes. In a ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

The detailed results were published in The New England Journal of Medicine and were presented at ObesityWeek 2024.

Artemis Bayandor from Illinois in the US lost over a stone after starting to take game-changing weight-loss jabs, but like ...

Jim Gaffigan has a sleek new look to match his recent Hollywood renaissance, which includes his hilarious turn on SNL as vice ...

Eli Lilly’s weight-loss drug, tirzepatide, has shown promising results in preventing diabetes. After three years of weekly ...

Comedian Jim Gaffigan, whose new stand-up special, 'The Skinny', premieres on Nov. 22 on Hulu, has lost 50 lbs. with the help ...

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...